ZWI Therapeutics
Latest round
- Series A
Last raised
- Mar 2021
Total raised
- $5M
Investors
- 2
About ZWI Therapeutics
Established in 2020 and based in Massachusetts, US, ZWI Therapeutics, Inc.e. novel proteins developed using their zwitterionic polymer technology. As of 2024, the company is headed by its CEO Ed Mascioli. The company offers a superior polymer, polyCarboxyBetaine (pCB) which has physio-chemical properties and helps in reducing immunogenicity. The firm polymer technology helps in the development of nanoparticles. Moreover, the firm pCB helps in developing hydrogel which has multiple applications such as cellular therapies, etc.
Who invested in ZWI Therapeutics
2 investors across 1 round
See all investors in ZWI Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Mar 17, 2021
Amount
$5M
Investors
Questions about ZWI Therapeutics
Who invested in ZWI Therapeutics?
ZWI Therapeutics has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has ZWI Therapeutics raised?
ZWI Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did ZWI Therapeutics last raise money?
ZWI Therapeutics's most recent round on record is a Series A, in Mar 2021.
What does ZWI Therapeutics do?
Established in 2020 and based in Massachusetts, US, ZWI Therapeutics, Inc.
Where is ZWI Therapeutics headquartered?
ZWI Therapeutics is headquartered in Watertown, US.
Which VCs invest in companies like ZWI Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at ZWI Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like ZWI Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.